Cargando…
The effect size, study design, and development experience in commercially sponsored studies for new drug applications in approved drugs
Pharmaceutical companies incorporate different features into the trials for new drug applications (NDAs) to render them efficient, making use of their experience. The objective of this analysis was to examine the associations between outcome and features related to study design and clinical developm...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320132/ https://www.ncbi.nlm.nih.gov/pubmed/25674470 http://dx.doi.org/10.1186/2193-1801-3-740 |